Literature DB >> 3549322

The effect of propranolol on urinary prostaglandin E2 after frusemide administration in healthy subjects.

A Fujimura, H Kajiyama, A Ebihara.   

Abstract

We have evaluated the effect of propranolol on urinary prostaglandin E2 (PGE2) excretion after frusemide administration in 8 healthy subjects. Urine was collected for 60 min after frusemide administration (20 mg intravenously) with or without propranolol pretreatment, and urinary excretion of PGE2, frusemide, and sodium were determined. Plasma renin activity (PRA) was also measured before and 60 min after frusemide administration. Urinary PGE2 excretion after frusemide administration and frusemide-stimulated PRA were reduced after propranolol pretreatment. However, urine volume and the urinary excretion of frusemide and sodium were not influenced by propranolol pretreatment. These results suggest that urinary PGE2 excretion after frusemide administration may be reduced by propranolol and that the mechanism responsible for the effect of propranolol on the frusemide-induced renal PGE2 production may be, at least in part, secondary to inhibition of the renin-angiotensin system.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3549322     DOI: 10.1007/BF00606639

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  17 in total

1.  Studies on rat kidney 15-hydroxy-prostaglandin dehydrogenase.

Authors:  J T Wright; C N Corder; R Taylor
Journal:  Biochem Pharmacol       Date:  1976-07-15       Impact factor: 5.858

2.  Effects of metoprolol and propranolol on furosemide-stimulated renin release in healthy subjects.

Authors:  P O Attman; M Aurell; G Johnsson
Journal:  Eur J Clin Pharmacol       Date:  1975-04-04       Impact factor: 2.953

3.  Local anesthetics, chlorpromazine and propranolol inhibit stimulus-activation of phospholipase A2 in human platelets.

Authors:  J Y Vanderhoek; M B Feinstein
Journal:  Mol Pharmacol       Date:  1979-07       Impact factor: 4.436

4.  Separation and quantitative analysis of furosemide and 4-chloro-5-sulfamoylanthranilic adid (CSA) by high pressure liquid chromatography.

Authors:  M L MacDougall; D W Shoeman; D L Azarnoff
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1975-02

5.  Urinary prostaglandins. Identification and origin.

Authors:  J C Frölich; T W Wilson; B J Sweetman; M Smigel; A S Nies; K Carr; J T Watson; J A Oates
Journal:  J Clin Invest       Date:  1975-04       Impact factor: 14.808

6.  Radioimmunoassay measurement of prostaglandins E, A, and F in human plasma.

Authors:  B M Jaffe; H R Behrman; C W Parker
Journal:  J Clin Invest       Date:  1973-02       Impact factor: 14.808

7.  Alpha- and beta-adrenergic stimulation of arachidonic acid metabolism in cells in culture.

Authors:  L Levine; M A Moskowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

8.  Effect of propranolol, practolol and atenolol on human platelet thromboxane formation and plasma levels of prostaglandins 6-keto-F1 alpha and E2.

Authors:  R Brandt; E Seppälä; J Nowak; H Vapaatalo
Journal:  Prostaglandins Leukot Med       Date:  1984-11

9.  Inhibition of frusemide-induced natriuresis by indomethacin in patients with the nephrotic syndrome.

Authors:  R G Tiggeler; R A Koene; P G Wijdeveld
Journal:  Clin Sci Mol Med       Date:  1977-02

Review 10.  Arachidonic acid metabolism, prostaglandins and the kidney.

Authors:  D J Levenson; C E Simmons; B M Brenner
Journal:  Am J Med       Date:  1982-02       Impact factor: 4.965

View more
  1 in total

1.  Effect of propranolol on urinary prostaglandin E2 excretion and renal interlobar arterial blood flow after furosemide administration in patients with hepatic cirrhosis.

Authors:  N Ljubicić; A Bilić; V Plavsić
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.